Mon, January 14, 2019
Fri, January 11, 2019
Thu, January 10, 2019
Wed, January 9, 2019
Tue, January 8, 2019
Mon, January 7, 2019
Fri, January 4, 2019
Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018
Fri, December 28, 2018
Thu, December 27, 2018
Wed, December 26, 2018
Fri, December 21, 2018
Thu, December 20, 2018
Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018

Jason Gerberry Upgraded (TEVA) to Strong Buy on, Jan 3rd, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. upgraded-teva-to-strong-buy-on-jan-3rd-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Jason Gerberry of B of A Securities, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy on, Jan 3rd, 2019.

Jason has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 3 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Ami Fadia of "Leerink Swann" Upgraded from Sell to Hold on, Monday, October 1st, 2018
  • Tim Chiang of "BTIG" Upgraded from Strong Sell to Hold on, Monday, September 17th, 2018
  • Vamil Divan of "Credit Suisse" Maintained at Hold with Increased Target to $26 on, Monday, September 17th, 2018


These are the ratings of the 3 analyists that currently disagree with Jason


  • David Risinger of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $27 on, Monday, November 5th, 2018
  • Jami Rubin of "Goldman Sachs" Maintained at Strong Buy and Held Target at $30 on, Monday, October 1st, 2018
  • Irina Rivkind Koffler of "Mizuho" Maintained at Strong Buy with Increased Target to $29 on, Monday, September 17th, 2018

Publication Contributing Sources